Compile Data Set for Download or QSAR
Report error Found 181 Enz. Inhib. hit(s) with all data for entry = 2488
TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368342(US10227338, Example 129)
Affinity DataIC50: 4nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368343(US10227338, Example 130)
Affinity DataIC50: 6nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368340(US10227338, Example 127)
Affinity DataIC50: 8nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368341(US10227338, Example 128)
Affinity DataIC50: 9nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368324(US10227338, Example 111)
Affinity DataIC50: 10nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368272(US10227338, Example 55)
Affinity DataIC50: 12nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368258(US10227338, Example 50 | US10227338, Example 40)
Affinity DataIC50: 13nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368220(US10227338, Example 32 | US10227338, Example 1)
Affinity DataIC50: 17nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368318(US10227338, Example 105)
Affinity DataIC50: 20nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368321(US10227338, Example 108)
Affinity DataIC50: 20nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368327(US10227338, Example 116 | US10227338, Example 114)
Affinity DataIC50: 20nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368332(US10227338, Example 119)
Affinity DataIC50: 20nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368339(US10227338, Example 126)
Affinity DataIC50: 20nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368347(US10227338, Example 134)
Affinity DataIC50: 20nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368239(US10227338, Example 20)
Affinity DataIC50: 21nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368298(US10227338, Example 81)
Affinity DataIC50: 23nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368221(US10227338, Example 2)
Affinity DataIC50: 26nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368256(US10227338, Example 38)
Affinity DataIC50: 27nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368344(US10227338, Example 131)
Affinity DataIC50: 27nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368284(US10227338, Example 67)
Affinity DataIC50: 28nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368297(US10227338, Example 80)
Affinity DataIC50: 28nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368308(US10227338, Example 95)
Affinity DataIC50: 30nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368294(US10227338, Example 77)
Affinity DataIC50: 32nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368220(US10227338, Example 32 | US10227338, Example 1)
Affinity DataIC50: 35nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368305(US10227338, Example 92)
Affinity DataIC50: 40nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368311(US10227338, Example 121 | US10227338, Example 98)
Affinity DataIC50: 40nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368316(US10227338, Example 103)
Affinity DataIC50: 40nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368223(US10227338, Example 4)
Affinity DataIC50: 44nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368249(US10227338, Example 31)
Affinity DataIC50: 44nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368289(US10227338, Example 72)
Affinity DataIC50: 46nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368243(US10227338, Example 24)
Affinity DataIC50: 49nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368287(US10227338, Example 70)
Affinity DataIC50: 50nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368322(US10227338, Example 109)
Affinity DataIC50: 50nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368327(US10227338, Example 116 | US10227338, Example 114)
Affinity DataIC50: 50nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368336(US10227338, Example 123)
Affinity DataIC50: 50nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368354(US10227338, Example 141)
Affinity DataIC50: 50nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368254(US10227338, Example 36)
Affinity DataIC50: 51nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368236(US10227338, Example 17)
Affinity DataIC50: 53nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368257(US10227338, Example 49 | US10227338, Example 39)
Affinity DataIC50: 53nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368255(US10227338, Example 37)
Affinity DataIC50: 58nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368310(US10227338, Example 97)
Affinity DataIC50: 60nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368311(US10227338, Example 121 | US10227338, Example 98)
Affinity DataIC50: 60nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368352(US10227338, Example 139)
Affinity DataIC50: 60nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368240(US10227338, Example 52 | US10227338, Example 21)
Affinity DataIC50: 61nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368240(US10227338, Example 52 | US10227338, Example 21)
Affinity DataIC50: 66nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368244(US10227338, Example 26)
Affinity DataIC50: 66nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368323(US10227338, Example 110)
Affinity DataIC50: 70nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368325(US10227338, Example 115 | US10227338, Example 112)
Affinity DataIC50: 70nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368277(US10227338, Example 60)
Affinity DataIC50: 73nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM368309(US10227338, Example 96)
Affinity DataIC50: 80nMAssay Description:In order to measure the sodium ion channel blocking effect, an IonFlux16 Auto patch clamp system (Fluxion, Inc.) and a plate for exclusive use were u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 181 total ) | Next | Last >>
Jump to: